Tocilizumab Subcutaneous Injection (RoActemra®)
What the buyer wrote
The supply of Tocilizumab Subcutaneous Injections (RoActemra®) to NHS Scotland which used to treat licensed indications. This medicine is not being procured to treat Covid-19.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Tocilizumab Subcutaneous Injection (RoActemra®)
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Where
- in Scotland
- Kind of work
- Pharmacy and medicines
Who the buyer named
Gordon Ralph was the named contact on this notice.